Effects of Combined serum and fluticasone in chronic rhinosinusitis with polyposis patients

Effects of Combined serum and fluticasone in chronic rhinosinusitis with polyposis in post op FESS patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191009045040N1

Enrollment

Registered

2022-12-17

Start date

2022-12-22

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Nasal polyp. Condition 2: Chronic sinusitis. Nasal polyp Chronic sinusitis

Interventions

Intervention 1: BD nasal irrigation with N/S& DeXMT (16mg) & BeTMT(8mg) & BrMHX (4mg). Intervention 2: Control group: Fluticasone spray +BD nasal irrigation with N/S.

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients between the ages of 18 and 50, with chronic rhinosinusitis with polyposis

Exclusion criteria

Exclusion criteria: without mucociliary disease, heart disease, diabetes, and no history of malignancy

Design outcomes

Primary

Measure	Time frame
Symptoms of rhinosinusitis include; Sneezing, runny nose, coughing, post-nasal discharge, thick nasal discharge, dizziness, ear fullness, pain and pressure in the ears, pain and pressure in the face, lack of taste or smell, nasal obstruction/congestion. Timepoint: 21 days after treatment. Method of measurement: SNOT22 score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Safavi

Shahid Beheshti University of Medical Sciences

md.safavi.naini@gmail.com+98 21 2627 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026